IGHE and cancer: In vitro interrogation of tumour cell killing determined that MOv18 IgE predominantly induces cancer cell ADCC by monocytes, as well as ADCP, when monocytes are IL-4-stimulated to induce expression of low-affinity IgE receptor, CD23 [132].